Glomerular C4d Staining Does Not Exclude a C3 Glomerulopathy

Geetika Singh(All India Institute of Medical Sciences), Amit Kumar Dinda(All India Institute of Medical Sciences), Adarsh Barwad(All India Institute of Medical Sciences), Lavleen Singh(All India Institute of Medical Sciences), Arvind Bagga(All India Institute of Medical Sciences), Shamresh Kumar Singh(All India Institute of Medical Sciences), Soumita Bagchi(All India Institute of Medical Sciences), Aditi Sinha, Sanjay Kumar Agarwal(Institute of Botany), Immanuel Pradeep(All India Institute of Medical Sciences), Pankaj Hari(Indian Council of Medical Research), Aasma Nalwa(All India Institute of Medical Sciences)
Kidney International Reports
February 13, 2019
10.1016/j.ekir.2019.02.006
Cited by 24

Related Papers

Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic Syndrome
|Journal of the American Society of Nephrology|2004|415
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|256
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
|Kidney International|2013|216